跳至主要内容
临床试验/NCT03759834
NCT03759834已完成不适用

Cochlear Promontory Stimulation for Treatment of Tinnitus: Towards Developing an Implantable Device

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
25
试验地点
2
主要终点
Change in Short Term Relief of Tinnitus as Measured by the Tinnitus Handicap Inventory

研究概览

简要总结

Tinnitus is the perception of sound when no external noise is present. The Center for Disease Control (CDC) estimates over 50 million - nearly 15% of the general public -experience some form of tinnitus. Roughly 20 million people struggle with burdensome chronic tinnitus, with 2 million experiencing extreme and debilitating symptoms.

The 2014 Clinical Practice Guideline on tinnitus from the American Academy of Otolaryngology - Head and Neck Surgery summarized the existing state of tinnitus management by stating "A cure for primary tinnitus does not yet exist, and despite claims to the contrary, no method has been proven to provide long-term suppression of tinnitus."

The purpose of this study is to look at the safety and efficacy of cochlear promontory stimulation in the short term relief of tinnitus. The secondary goal of the study is to determine the optimum region(s) of the cochlear promontory in planning for an implantable electrical device for long term tinnitus suppression.

详细描述

Candidate subjects will undergo a temporal bone Computed Tomography (CT) scan, contrast enhanced head Magnetic Resonance Imaging (MRI), audiogram with immittance testing, pitch and level matching of tinnitus, Distortion Product Otoacoustic Emissions (DPOAE) and Auditory Brainstem Response (ABR) testing prior to promontory stimulation. Head MRI, DPOAE, audiogram and immittance testing are considered clinically routine for assessment of asymmetric tinnitus. Temporal bone CT, ABR, tinnitus pitch, level matching, masking levels and residual inhibition testing are not standard clinical assessments for asymmetric tinnitus. In addition, subjects will complete the Tinnitus Handicap Inventory (THI), Tinnitus Functional Index (TFI) and Visual Analog Scale (VAS) questionnaires three separate times within the week prior to promontory stimulation testing. Additional testing for comorbid anxiety and depressive conditions will be a screening Generalized Anxiety Disorder (GAD7), Patient Health Questionnaire (PHQ8), and short Health Anxiety Inventory (HAI-S). The NEO Personality Inventory (NEO PI) will be administered to provide baseline information. The initial session of promontory stimulation will define optimal stimulation parameters (i.e., location, current level, pulse-width, phase polarity), where maximal tinnitus suppression occurs with minimal or no auditory percept. After these parameters are established, the patient will complete the THI, TFI, and VAS immediately prior to stimulation, during stimulation, and following completion of stimulation at 10-minutes, 1-hour, 24-hours, 48-hours, and 1-week following completion of stimulation. In addition, pitch and level matching of tinnitus will be completed immediately upon completion of each promontory stimulation session. Each patient will undergo three successive treatments separated by 1-week. Prior to each treatment, the patient will receive an audiogram and DPOAE testing to document interval safety. At the conclusion of the study, subjects will be asked about their willingness to undergo surgical implantation of a device capable of long-term scheduled or on-demand electrical stimulation for tinnitus suppression

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

The electrode will be placed in the middle ear. The patient and investigator will be blinded to the "on-off" status of the device. The patient will report if they have improvement of their tinnitus while both the patient and investigator are blinded to the "on-off" status.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Normal to moderate sensorineural hearing loss (based on pure tone audiometry (PTA) of 500, 1000 and 2000 Hz) and a word recognition score equal to or greater than 60%
  • Asymmetric or unilateral subjective tonal tinnitus
  • Tinnitus that is disruptive
  • Determined by THI score (in the severe range i.e. ≥56/100)
  • TFI (in the severe range i.e. ≥52/100)
  • Tinnitus VAS (≥ 5/10 )
  • Tinnitus that is intractable, and has not been ameliorated by conventional measures such as a hearing aid or masking
  • Normal contrast-enhanced MRI of the head

排除标准

  • Tinnitus present less than 6 months or longer than 12 years; it is permissible to include people who have had intermittent or constant tinnitus longer than 12 years as long as it was not perceived as severe longer than 12 years
  • History of brain or major ear surgery
  • Prior major head trauma
  • Ongoing clinical diagnosis of depression or anxiety; for the purposes of this study, it is permissible to include people who:
  • have a past history of clinically diagnosed depression or anxiety that is no longer currently active; or
  • people who have depressive or anxious symptoms that are thought to primarily result from severe tinnitus
  • a. Determined by screening using the GAD 7, PHQ8, and HAI-S
  • GAD7 > 9 (indicates clinically significant anxiety)
  • PHQ > 9 (indicates clinically significant depression)
  • HAI-S > 25 (hypochondriacal level illness anxiety)
  • Inability to assess, continue or complete trial
  • Currently on regularly scheduled antidepressants, anxiolytics or antipsychotics; for this study, it is permissible to include people who use such medications at lower doses as a sleep aid or for people who intermittently use such medications for situational anxiety (e.g., Ativan before airplane travel)
  • Active use of other tinnitus treatments; for the purposes of this study it is permissible to include people who prefer to use a hearing aid to amplify ipsilateral hearing loss
  • Known pregnancy

结局指标

主要结局

Change in Short Term Relief of Tinnitus as Measured by the Tinnitus Handicap Inventory

时间窗: Baseline to 4 months

The Tinnitus Handicap Inventory (THI) has 25 questions with possible answers of Yes (4 points), Sometimes (2 points), and No (0 points). Scores categories are (1-16: Slight or no handicap - Grade 1), (18-36: Mild handicap - Grade 2), (38-56: Moderate handicap - Grade 3), (58-76: Severe handicap - Grade 4), (78-100: Catastrophic handicap - Grade 5). Total score ranges from 0 to 100 with higher scores indicating a worse outcome.

次要结局

  • Optimal Location of Tinnitus Relief(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))
  • Auditory Feedback(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))
  • Tactile Feedback(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))
  • Change in Short Term Relief of Tinnitus as Measured by the Tinnitus Functional Index(Baseline to 4 months)
  • Change in Short Term Relief of Tinnitus as Measured by the Visual Analog Scale(Baseline to 4 months)
  • Tactile Feedback(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))
  • Optimal Location of Tinnitus Relief(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))
  • Auditory Feedback(Immediately after electrical stimulation procedure (approximately 1 min after stimulation))

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew L. Carlson, M.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验